Tumor lysis syndrome in small cell lung cancer

Medical Oncology

Volumn 18, Issue 2, 2001, Pages 149-151

  Kallab, A M ^a   Jillella, A P ^a  

^a RM BAA 5407 ^*  (United States)

Author keywords

Small cell lung cancer; Tumor lysis syndrome

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CELL DEATH; HUMAN; INCIDENCE; LUNG SMALL CELL CANCER; LYMPHOPROLIFERATIVE DISEASE; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; FATAL OUTCOME; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; TUMOR LYSIS SYNDROME;

EID: 0034815718     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:18:2:149     Document Type: Article

References (10)

1. Tumor lysis syndrome
2. Acute tumor lysis syndrome in patients with high grade non-Hodgkin's lymphoma
3. Chemotherapy of lung cancer
4. Tumor lysis syndrome after induction chemotherapy in small cell lung carcinoma
5. Tumor lysis syndrome in small cell carcinoma and other solid tumors
6. Tumor lysis syndrome in metastatic small cell cancer
7. The tumor lysis syndrome
8. Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma
9. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: A case report and review of the literature
10. Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin